But that doesnt mean [archived link] its guaranteed to happen or that you have to take a GLP-1 RA forever
There is no indication that GLP-1s have negatively impacted medtech volumes or pricing
In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
The pill may also be cheaper, but this is yet to be confirmed
But even with its success, many patients are already asking: What comes next? Here are the most common reasons: Insurance and cost challenges: Even when Ozempic is prescribed, coverage can be patchy, and monthly costs remain high for many patients
Vyvanse: Conditions treated Vyvanse is FDA approved to treat ADHD and binge-eating disorder, and studies have confirmed its effectiveness in improving adult ADHD and reducing binge-eating episodes